WIMI Q4 2020 Earnings EPS Misses Estimates Amidst Market Decline ARTNA Q3 2025 Earnings Slight EPS Beat Amid Steady Utility Performance Danaos Corporation Q1 2026 Earnings Modest EPS Miss Amid Stable Charter Operations COCP Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Aytu BioPharma Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds